Loading...

FITC anti-human CD14 Antibody

Pricing & Availability
Clone
M5E2 (See other available formats)
Regulatory Status
RUO
Workshop
III 329
Other Names
LPS receptor
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
M5E2_FITC_100507
Human peripheral blood monocytes stained with M5E2 FITC
  • M5E2_FITC_100507
    Human peripheral blood monocytes stained with M5E2 FITC
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
301803 25 tests 40€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
301804 100 tests 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD14 is a 53-55 kD glycosylphosphatidylinositol (GPI)-linked membrane glycoprotein also known as LPS receptor. CD14 is expressed at high levels on monocytes and macrophages, and at lower levels on granulocytes. Some dendritic cell populations such as interfollicular dendritic cells, reticular dendritic cells, and Langerhans cells have also been reported to express CD14. As a high-affinity receptor for LPS, CD14 is involved in the clearance of gram-negative pathogens, and in the upregulation of adhesion molecules and expression of cytokines in monocytes and neutrophils.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human,Cynomolgus,Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Full-length human CD14 protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The M5E2 antibody inhibits monocyte activation and cytokine production induced by LPS. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections, blocking of LPS stimulation4, and immunofluorescence microscopy5. Clone M5E2 is not recommended for immunohistochemical staining of formalin-fixed paraffin-embedded sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 301861 and 301862).

Application References
  1. McMichael A, et al. 1987. Leucocyte Typing III. Oxford University Press. New York.
  2. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York. (IHC-F)
  3. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  4. Power CP, et al. 2004. J. Immunol. 173:5229. (Block)
  5. Williams KC, et al. 2001. J. Exp. Med. 193:905.
  6. Iwamoto S, et al. 2007. J. Immunol. 179:1449. (FC) PubMed
  7. Santer DM, et al. 2010. J. Immunol. 485:4739. PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Zizzo G, et al. 2012. J. Immunol. 189:3508. PubMed
  10. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
  11. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  2. Shoda H, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1308-y. PubMed
  3. Meng Y,et al. 2017. Cell Death Dis. . 10.1038/cddis.2017.505. PubMed
  4. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  5. Schulthess J et al. 2019. Immunity. 50(2):432-445 . PubMed
  6. Yang X, et al. 2019. Mol Med Rep. 19:1083. PubMed
  7. Kletting S, et al. 2017. ALTEX. 35:211. PubMed
  8. Rao Z, et al. 2019. J Immunol. 203:1031. PubMed
  9. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  10. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  11. Lin F, et al. 2020. Int J Oncol. 56:151. PubMed
  12. Zhang D, et al. 2020. Oncoimmunology. 9:1744921. PubMed
  13. Crifò B, et al. 2019. J Immunol. 202:1521. PubMed
  14. Wang D, et al. 2020. J Cell Mol Med. 24:4212. PubMed
  15. Chiu YL, et al. 2018. Immun Ageing. 15:27. PubMed
  16. Woolsey C, et al. 2020. Scientific Reports. 10(1):3071.. PubMed
  17. Pucino V, et al. 2020. Cell Metabolism. 30(6):1055-1074.e8.. PubMed
  18. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  19. Wiernik A, et al. 2013. Clin Cancer Res. 19:3844. PubMed
  20. Donini M, et al. 2011. Prostate. 72:566. PubMed
  21. Hecker A, et al. 2015. J Immunol. 195: 2325-2334. PubMed
  22. Autenrieth S, et al. 2015. Clin Transl Immunology. 4:50. PubMed
  23. Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed
  24. Poran A, et al. 2020. Cell Reports Medicine. 1(8):100141. PubMed
  25. Jackson R, et al. 2020. Viruses. 12:00. PubMed
  26. Pierini S, et al. 2020. JCI Insight. 5:00. PubMed
  27. Zhao M, et al. 2021. Frontiers in Cell and Developmental Biology. 9:652972. PubMed
  28. Qu M, et al. 2021. Frontiers in Oncology. 11:659720. PubMed
  29. Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
  30. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  31. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  32. Zavareh RB, et al. 2020. Cell Chemical Biology. 28(2):158-168.e5. PubMed
  33. Wang H, et al. 2020. Cell Stem Cell. 28(3):535-549.e8. PubMed
  34. Sutton HJ, et al. 2021. Cell Reports. 34(6):108684. PubMed
  35. Hiatt J, et al. 2021. Cell Reports. 35(6):109105. PubMed
  36. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  37. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  38. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  39. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  40. Jankeel A, et al. 2020. J Virol. :94. PubMed
  41. Wang Z, et al. 2020. J Cell Mol Med. . PubMed
  42. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  43. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  44. Wells DK, et al. 2020. Cell. 183:818. PubMed
  45. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  46. Saha R, et al. 2021. Sci Rep. 11:18849. PubMed
  47. Wu Q, et al. 2022. Cancer Immunol Res. 10:182. PubMed
  48. Ceglia V, et al. 2022. Front Immunol. 12:786144. PubMed
  49. Meng Q, et al. 2022. Oncol Lett. 23:83. PubMed
  50. Reyes M, et al. 2021. Sci Transl Med. 13:. PubMed
  51. Zheng H, et al. 2022. Cell Rep. 39:110864. PubMed
  52. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  53. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  54. Zhao Y, et al. 2021. Front Immunol. 12:665442. PubMed
  55. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  56. Yao J, et al. 2022. Front Pharmacol. 13:876076. PubMed
  57. Chen X, et al. 2022. Front Bioeng Biotechnol. 10:915181. PubMed
  58. Qi F, et al. 2022. Oncol Lett. 24:273. PubMed
  59. Fekete T, et al. 2020. Front Immunol. 11:572960. PubMed
  60. Wang SQ, et al. 2021. J Viral Hepat. 28:795. PubMed
  61. Liao HQ, et al. 2021. Am J Reprod Immunol. 86:e13406. PubMed
  62. Langnau C, et al. 2021. Arterioscler Thromb Vasc Biol. 41:2080. PubMed
  63. Ma X, et al. 2022. Front Oncol. 12:855570. PubMed
  64. Li F, et al. 2022. Front Pharmacol. 13:1001552. PubMed
  65. Grivas A, et al. 2022. Front Immunol. 13:964274. PubMed
  66. Bencze D, et al. 2022. Int J Mol Sci. 23:. PubMed
  67. Aarsund M, et al. 2022. Cancer Immunol Immunother. 71:2227. PubMed
  68. Abe I, et al. 2022. Dev Cell. 57:2623. PubMed
  69. Matsumoto H, et al. 2023. Front Immunol. 13:978435. PubMed
  70. Aabling RR, et al. 2023. Regen Ther. 23:67. PubMed
  71. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  72. Shen WY, et al. 2023. iScience. 26:106805. PubMed
  73. Jiang D, et al. 2023. Nat Commun. 14:3642. PubMed
  74. Wang Y, et al. 2023. Mol Med Rep. 28:. PubMed
RRID
AB_314185 (BioLegend Cat. No. 301803)
AB_314186 (BioLegend Cat. No. 301804)

Antigen Details

Structure
GPI-linked membrane glycoprotein, 53-55 kD
Distribution

Monocytes, macrophages, granulocytes (low)

Function
LPS receptor, clearance of Gram-negative pathogens
Ligand/Receptor
LPS
Cell Type
Granulocytes, Macrophages, Monocytes, Neutrophils
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family
CD Molecules
Antigen References

1. Stocks S, et al. 1990. Biochem. J. 268:275.
2. Wright S, et al. 1990. Science 249:1434.

Gene ID
929 View all products for this Gene ID
UniProt
View information about CD14 on UniProt.org
Go To Top Version: 4    Revision Date: 11/05/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account